ClinicalTrials.Veeva

Menu

Lidocaine Patch Versus Intravenous Lidocaine in Pain Relief After Laparoscopy

A

Aswan University Hospital

Status

Unknown

Conditions

Infertility

Treatments

Drug: lidocaine patches
Drug: IV lidocaine
Drug: IV saline infusion

Study type

Interventional

Funder types

Other

Identifiers

NCT04506034
aswu/277/7/18

Details and patient eligibility

About

To evaluate the efficacy of lidocaine patch applied around wound in laparoscopic gynecologic surgery in reduction of postoperative pain and illus compared to intravenous lidocaine infusion and placebo.

Full description

Postoperative pain after gynecologic surgery is a challenging problem associated with increased morbidity and cost. The inflammatory response to surgery plays a crucial rule in inducing postoperative illus. Systemic local anesthetics proved to have anti-inflammatory properties that may be beneficial in preventing ileus added to its analgesic actions. The lidocaine patch evaluated in many types of pain with promising results. The study try to evaluate the patch in perioperative field as a more simple and safe technique than the intravenous route.

Enrollment

150 estimated patients

Sex

Female

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • female undergoing elective gynecologic surgery

Exclusion criteria

  • known allergy to lidocaine,
  • respiratory or cardiac dysfunction, arrhythmia, treatment with antiarrhythmic drugs,
  • inflammatory bowel disease (Crohn's disease or ulcerative colitis)
  • hepatic, renal
  • chronic use of analgesics or corticosteroids

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

150 participants in 3 patient groups, including a placebo group

lidocaine patches
Experimental group
Description:
for every port entry site from the three in ports of laparoscope, patients received three lidocaine patches 5% (Lidoderm® , Endo Pharmaceuticals, Chadds Ford, PA). Each patch measured 10 cm × 14 cm and contains (700 mg), was divided into two equal parts, six parts applied two of it around one port entry site that marked before sterilization and just before induction of anesthesia. The patches not changed until removed after return of bowel function or on the maximum at fifth postoperative day.
Treatment:
Drug: lidocaine patches
IV lidocaine
Active Comparator group
Description:
received i.v. lidocaine infusion after induction of anesthesia, 2 mg/min if body weight \>70 kg or 1 mg/min if body weight \<70 kg.
Treatment:
Drug: IV lidocaine
IV saline infusion
Placebo Comparator group
Description:
received i.v. saline infusion.
Treatment:
Drug: IV saline infusion

Trial contacts and locations

1

Loading...

Central trial contact

nahla w Shady, md; hany f Sallam, md

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems